Maplight files amended Form 144 for proposed RSU sales

Maplight Therapeutics, Inc. submission amends a Form 144 notice reporting proposed sales of common stock tied to previously granted restricted stock units.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submission amends a Form 144 notice reporting proposed sales of common stock tied to previously granted restricted stock units. The filing lists grants of 1,668 shares (07/30/2023), 853 shares (11/09/2023), and 3,012 shares (05/02/2024). The broker shown is Jefferies LLC.

Key Figures

RSU grant (07/30/2023): 1,668 shares RSU grant (11/09/2023): 853 shares RSU grant (05/02/2024): 3,012 shares +1 more

4 metrics

RSU grant (07/30/2023) 1,668 shares Grant date 07/30/2023

RSU grant (11/09/2023) 853 shares Grant date 11/09/2023

RSU grant (05/02/2024) 3,012 shares Grant date 05/02/2024

Filing amendment date shown 04/15/2026 Amendment date on the header

Key Terms

Restricted Stock Unit, Form 144/A, Jefferies LLC

3 terms

Restricted Stock Unit financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Form 144/A regulatory

"144/A: Filer Information"

Jefferies LLC other

"Jefferies LLC 520 Madison Ave 4th Fl New York NY 10022"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MPLT's Form 144/A report?

It reports proposed sales of common stock from restricted stock unit grants by insiders. The filing lists grants of 1,668, 853, and 3,012 shares on specific grant dates.

Who is handling the proposed sales for MPLT?

Jefferies LLC is listed as the broker for the transaction. The filing shows Jefferies' New York address and indicates broker involvement in planned dispositions.

Are the exact sale dates or prices in the MPLT 144/A?

No specific sale dates or prices are provided in the excerpt. The filing amends the prior notice and lists grant dates and share counts only.

Do the listed RSU counts represent shares being sold for MPLT?

The filing lists RSU grant amounts of 1,668, 853, and 3,012 shares associated with proposed sales. It ties each count to its grant date as reported.

Does the MPLT filing show shares sold in the past three months?

The excerpt includes a heading for securities sold during the past three months but does not display specific recent-sale numbers in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001789970
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001974158-26-000046
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Hanson Kristopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Ave 4th Fl New York NY 10022	1827	49365.54	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1668	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			853	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3012	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection w/ RSU vesting
Date of Notice	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kristopher Hanson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)